Amarin Corp Plc (AMRN)

[couldbebetter]

JRoon71, Amarin's great and illustrious management team did nothing
to differentiate Vascepa against Lovaza (branded & generic) which are
not even Cardiovascular drugs. So why would take any initiative now?
Simply put, I don't believe that AMRN management cares.

Face it, this management team has fumbled the ball too many times.
I thought KM was supposed to be the expert on getting reimbursements
in Europe, yet the most important country for Europe blindsided "the expert."
I used to believe that AMRN would have been acquired long ago for
the potential value of Europe. That a BP would want to handle the
reimbursement negotiations with their own skilled professionals.
The AMRN team screwed up the US, and may do the same with Europe.
China seems messed up as well. Where does it end with these guys?